DocGo (NASDAQ:DCGO) Announces Quarterly Earnings Results, Misses Estimates By $0.10 EPS

Posted by Brenda Bartman on May 13th, 2026

DocGo (NASDAQ:DCGO – Get Free Report) announced its earnings results on Monday. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.10), Zacks reports. The firm had revenue of $75.55 million during the quarter, compared to analyst estimates of $72.48 million. DocGo had a negative net margin of 62.23% and a negative return on equity of 38.52%.

Here are the key takeaways from DocGo’s conference call:

Raised 2026 revenue guidance to $300M–$315M while keeping full-year adjusted EBITDA guidance unchanged at a $5M–$10M loss, reflecting stronger top-line momentum but continued near-term profitability targets that remain negative.
SteadyMD accelerated in Q1 with >$9M revenue, ~1.1M visits and lab orders (up 38% YoY), and a new online-pharmacy contract for weight‑loss and general clinical services—management said SteadyMD drove the majority of the guidance increase.
Home-health and mobile phlebotomy are scaling quickly—management projects up to 75% growth in mobile phlebotomy in 2026, expanding into new territories (Upstate NY, Pennsylvania, launching Florida) and integrating lab systems and AI to improve margins.
Margin pressures and higher operating costs weighed on results—Q1 adjusted EBITDA was a $(10.2)M loss, with management citing temporary labor inefficiencies from rapid SteadyMD hiring and higher fuel costs as near-term drags on gross margin.
Near-term cash/working-capital pressure—cash fell to $59.9M at quarter-end, management collected ~$8M on April 1 but said roughly $13M from NYC HPD remains outstanding and is expected to be collected over the balance of 2026.

DocGo Stock Performance

DocGo stock traded down $0.00 during midday trading on Wednesday, reaching $0.59. The stock had a trading volume of 303,293 shares, compared to its average volume of 934,844. DocGo has a twelve month low of $0.49 and a twelve month high of $1.78. The stock has a market capitalization of $58.66 million, a PE ratio of -0.31 and a beta of 1.02. The stock’s 50-day simple moving average is $0.64 and its 200 day simple moving average is $0.82.

Institutional Trading of DocGo

Hedge funds and other institutional investors have recently modified their holdings of the business. Neuberger Berman Group LLC purchased a new stake in shares of DocGo during the fourth quarter worth about $29,000. Cerity Partners LLC purchased a new stake in shares of DocGo during the second quarter worth about $37,000. Public Employees Retirement System of Ohio purchased a new stake in shares of DocGo during the fourth quarter worth about $40,000. Engineers Gate Manager LP purchased a new stake in shares of DocGo during the second quarter worth about $52,000. Finally, Jain Global LLC purchased a new stake in shares of DocGo during the fourth quarter worth about $70,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a research note on Monday. Stifel Nicolaus dropped their price target on DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research note on Tuesday, March 17th. Canaccord Genuity Group decreased their target price on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 25th. Finally, Needham & Company LLC restated a “buy” rating and set a $3.00 target price on shares of DocGo in a research report on Tuesday, March 17th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $2.38.

Check Out Our Latest Analysis on DCGO

DocGo Company Profile

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.